KOR activation mediates the expression of mood disorder symptoms, such as dysphoria in chronic stress conditions [42,43,44], even though systemic KOR agonist administration would seem to exert a solid analgesic effect [45]. The gene discussed is OPRK1; the disease is mood disorder.